A Digital Therapy to Help Adults Cut Heavy Cannabis Use
Official title: A Comprehensive Digital Intervention to Reduce Heavy Cannabis Use
Funded at Mobile Health Interventions LLC · NIH-11408338 · Data updated 2026-11-12
A digital treatment delivered via a mobile app aims to help adults with cannabis use disorder reduce heavy cannabis use and stay engaged with self-managed wellness.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mobile Health Interventions LLC NIH-funded |
| Lab location | 1 site (Hastings on Hudson, United States) |
| Project start | February 1, 2025 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $1,186,132 |
| NIH project number | 2R44DA062420-02 |
| Project ID | NIH-11408338 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with cannabis use disorder who use cannabis heavily and are open to digital therapeutic approaches.
✕Less likely to help
Individuals unwilling to use mobile apps or digital therapies may not benefit.
What this research studies
This program develops Clear90 Rx, a prescription digital therapeutic for adults with cannabis use disorder, and a consumer version for self-management. It builds on proven delivery platforms and multimedia content to create an engaging mobile tool that uses adaptive personalization based on cannabis use patterns. The project includes a randomized controlled trial to test efficacy in 460 adults and aims to meet FDA software-as-a-medical-device requirements. If successful, the approach could provide a scalable, accessible option for people who struggle with heavy cannabis use and prefer digital support.
Why it matters
Potential benefit: If successful, patients could access an FDA-cleared digital therapy to reduce heavy cannabis use and improve everyday functioning.
How similar studies have gone: Previous digital platforms have shown uptake and behavior change, but there is no FDA-cleared digital therapeutic for cannabis use disorder yet.
Where this research is happening
-
Mobile Health Interventions LLC
Hastings on Hudson, United States Active
Researchers
- Principal investigator: Muench, Frederick John — Mobile Health Interventions LLC
- Study coordinator: Muench, Frederick John
Related research
Other NIH-funded projects on the same topics.
-
Hemp-derived CBD for reducing cannabis use in high-THC concentrate users
A randomized, placebo-controlled trial tests whether hemp-derived CBD can help adults who mainly use high-potency cannabis concentrates reduce their cannabis use.
-
Understanding how minority stress affects cannabis use in sexual minorities
A research project follows young adult sexual minorities to see how daily stress and coping help explain cannabis use and related problems.
-
Terminal cannabinoid CB1 receptor changes in schizophrenia and cannabis use
This grant studies how cannabis use and schizophrenia together affect a brain receptor (CB1) and what that could mean for memory and symptoms.
-
Cannabis policies and prenatal cannabis use: how laws affect moms and babies
This grant studies how changes in recreational cannabis laws influence cannabis use during pregnancy and health outcomes for mothers and children.
-
Genetic, Social, and Environmental Factors Shaping Early Cannabis Use in Youth
A study with young people will look at how genes, surroundings, and behavior come together to predict who might start using cannabis early and how to prevent it.
-
Cannabis use and how young adults feel about its effects
This grant helps a researcher study how young adults experience cannabis, including both positive and negative effects, and how these feelings relate to use patterns.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.